tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Imugene (AU:IMU)
ASX:IMU
Australian Market
IMU
Imugene
RESEARCH TOOLSreports

Imugene (IMU) Stock News & Sentiment

Compare
136 Followers
Imugene Updates Market on Director Paul Hopper’s Increased Performance Rights Holding
Premium
Company Announcements
Imugene Updates Market on Director Paul Hopper’s Increased Performance Rights Holding
2d ago
Imugene Plans New Issue of Convertible Notes and Warrants
Premium
Company Announcements
Imugene Plans New Issue of Convertible Notes and Warrants
3d ago
Imugene Enhances Financial Flexibility with Convertible Notes and Warrants Agreement
Premium
Company Announcements
Imugene Enhances Financial Flexibility with Convertible Notes and Warrants Agreement
3d ago
Imugene Advances Azer-cel Program with FDA Support and Strategic Partnerships
Premium
Company Announcements
Imugene Advances Azer-cel Program with FDA Support and Strategic Partnerships
5d ago
Imugene Announces Webinar on Positive FDA Feedback for Azer-cel Program
Premium
Company Announcements
Imugene Announces Webinar on Positive FDA Feedback for Azer-cel Program
14d ago
Imugene Receives FDA Support for Phase 3 Study of Azer-cel
Premium
Company Announcements
Imugene Receives FDA Support for Phase 3 Study of Azer-cel
14d ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
Premium
Company Announcements
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
20d ago
More AU:IMU News >

IMU News on the Web

Imugene Updates Market on Director Paul Hopper’s Increased Performance Rights Holding
TipRanks News
Neutral
FDA backs Imugene’s azer-cel treatment plan - ICYMI
Proactive Investors
Neutral
Health Check: It#8217;s thumbs up from the FDA for two ASX Car-T cancer drug developers
StockHead
Neutral
Imugene secures FDA backing for Azer-cel registration pathway
Proactive Investors
Neutral
Imugene hits 82% response rate in blood cancer trial - ICYMI
Proactive Investors
Neutral
Imugene lifts response rate to 82% in Phase 1b trial of azer-cel CAR-T therapy
Proactive Investors
Neutral
Health Check: It#8217;s deals galore as ASX biotechs strut the global stage
StockHead
Neutral
Imugene and JW Therapeutics launch collaborative program to bring CD19 CAR-T innovation to solid tum
Proactive Investors
Bullish

News Score - Last 7 Days

Neutral
AU:IMU
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:IMU’s Media Buzz Sentiment?
1 articles about AU:IMU were published this week. In an average week, 2.25 articles are published.
    What is AU:IMU’s weekly average amount of articles?
    In an average week, 2.25 articles about AU:IMU are published.
      What is AU:IMU’s News Sentiment?
      50% of articles about AU:IMU were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        TXG10x Genomics
        ANIPANI Pharmaceuticals
        HIKHikma Pharmaceuticals
        PCSAProcessa Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week